Work

Ways to accelerate the local implementation and adoption of the homologous recombination deficiency (HRD) testing in India.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e17596

Authors: Subhankar Basak, Bhavana Pathania, Srikanth Thota, Rohit Kodagali

Institutions: AstraZeneca (India), AstraZeneca (United States)

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410813323

FWCI: 0.373

Cites:

Cited by: 1

Related to: 10